Fullstack Engineer
Arkose LabsSalary not specified
- Full Time
- Junior (1 to 2 years)
About Arkose Labs
Arkose Labs focuses on preventing bot attacks in the cybersecurity sector. Their platform uses real-time risk assessments and machine learning analytics to identify and counteract malicious bot activities before they can inflict harm. A key feature of their offering is the Arkose MatchKey, which is designed to be a highly effective CAPTCHA, enhancing both security and user experience. Unlike many competitors, Arkose Labs aims to increase the cost and effort required for attackers, making bot attacks less appealing. The company's goal is to provide robust protection for digital assets, ensuring that clients can operate securely in an increasingly hostile online environment.
San Francisco, CaliforniaHeadquarters
2016Year Founded
$96.8MTotal Funding
SERIES_CCompany Stage
Cybersecurity, AI & Machine LearningIndustries
201-500Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Unlimited Paid Time Off
Flexible Work Hours
Paid Vacation
Generous nationwide parental leave policy
Employee Assistance Program
Mental Health Support
Gym Membership
Risks
Emerging AI-driven bot attacks could potentially outpace Arkose Labs' current defenses.
Competitors are developing advanced CAPTCHA alternatives challenging Arkose MatchKey's position.
The rise of DeFi platforms introduces new vectors for bot attacks Arkose must address.
Differentiation
Arkose Labs offers the world's first $1M warranties for credential stuffing and SMS toll fraud.
Arkose MatchKey is touted as the strongest CAPTCHA ever made, enhancing security measures.
Arkose Labs' AI-powered platform combines risk assessments with dynamic threat response.
Upsides
Arkose Labs is recognized as the 2023 Leader in Bot Detection and Mitigation.
The launch of Arkose Device ID enhances fraud detection and prevention capabilities.
Arkose Labs' protection measures for GPT applications address new attack vectors effectively.
Funding
Total raised$96.79 M
Latest valuation$350.00 M
StageSERIES_C
SERIES C
4/30/2021$70
$350.00 MSERIES A
3/31/2018$6
$30.00 MSEED
6/30/2017$2
$7.50 M